Soleno Therapeutics announced the appointment of Matthew Pauls, J.D., M.B.A, to its Board of Directors, effective August 15, 2023. Since 2020, Mr. Pauls has served as Chair of the Board of Directors and Chief Executive Officer of Savara, Inc., a biopharmaceutical company focused on rare respiratory diseases.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SLNO:
- Soleno Therapeutics reports Q2 EPS (81c), consensus (83c)
- SLNO Upcoming Earnings Report: What to Expect?
- Soleno Therapeutics to participate in a conference call with Cantor Fitzgerald
- Soleno Therapeutics files to sell 22.6M shares of common stock for holders
- Soleno Therapeutics management to meet virtually with Oppenheimer